QLS-101

DRUG2 trials

Sponsors

Qlaris Bio, Inc.

Conditions

Normal Tension Glaucoma (NTG)Ocular HypertensionPrimary Open Angle Glaucoma

Phase 2

Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).

CompletedNCT04830397

Qlaris Bio, Inc.Ocular Hypertension, Primary Open Angle Glaucoma

Start: 2021-03-31End: 2022-02-17Updated: 2025-01-17

A Study to Evaluate Safety and Tolerability of QLS-101 in NTG

CompletedNCT04857827

Qlaris Bio, Inc.Normal Tension Glaucoma (NTG)

Start: 2021-09-15End: 2022-08-26Updated: 2025-01-20